ArticleFrontiers in pharmacology2024

Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis.

Zhonghua Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.